| アブストラクト | Confounding by indication is a key challenge for pharmacoepidemiologists. Although self-controlled study designs address time-invariant confounding, indications sometimes vary over time. For example, infection might act as a time-varying confounder in a study of antibiotics and uveitis, because it is time-limited and a direct cause both of receiving antibiotics and uveitis. Methods for incorporating active comparators in self-controlled studies to address such time-varying confounding by indication have only recently been developed. In this paper we formalize these methods, and provide a detailed description for how the active comparator rate ratio can be derived in a self-controlled case series (SCCS): either by explicitly comparing the regression coefficients for a drug of interest and an active comparator under certain circumstances using a simple ratio approach, or through the use of a nested regression model. The approaches are compared in two case studies, one examining the association between thiazolidinediones and fractures, and one examining the association between fluoroquinolones and uveitis using the UK Clinical Practice Research DataLink. Finally, we provide recommendations for the use of these methods, which we hope will support the design, execution and interpretation of SCCS using active comparators and thereby increase the robustness of pharmacoepidemiological studies. |
|---|
| ジャーナル名 | American journal of epidemiology |
|---|
| Pubmed追加日 | 2024/7/20 |
|---|
| 投稿者 | Schultze, Anna; Brown, Jeremy; Logie, John; Cunnington, Marianne; Requena, Gema; Gillespie, Iain A; Evans, Stephen J W; Douglas, Ian; Galwey, Nicholas |
|---|
| 組織名 | London School of Hygiene and Tropical Medicine, London, UK.;Harvard University, Boston, U.S.;GlaxoSmithKline, Brentford, UK.;Analysis Group, London, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39030722/ |
|---|
